Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2008; 14(1): 85-89
Published online Jan 7, 2008. doi: 10.3748/wjg.14.85
Table 1 Baseline characteristics of patients with an index serum C-reactive protein (CRP) level ≤ 15 and > 15 mg/L
Index serum CRP level during relapse (mg/L)15> 15P-value
LCRPHCRP
n2767
Time of follow-up, yr (SD)10.8 (4.0)10.3 (3.7)NS
Demographic factors
Sex: men12 (44.4%)32 (47.7%)NS
Mean age, yr (SD)45 (13.5)42 (11.0)NS
Clinical features
Age at time of diagnosis (SD)27.0 (8.3)27.4 (10.8)NS
Duration of disease, yr (SD)18.0 (10.2)14.3 (7.3)NS
Localization
Terminal ileum6 (22.2%)8 (11.9%)NS
Colon7 ( 25.9%)31 (46.2%)
Ileocolon13 (48.1%)26 (38.8%)
Upper gastrointestinal1 (3.7%)2 (3.0%)
Behaviour
Non-stricturing non penetrating13 (48.1%)26 (38.8%)NS
Stricturing7 (25.9%)15 (22.4%)
Penetrating7 (25.9%)26 (38.8%)
Table 2 Subgroups with an index serum C-reactive protein (CRP) level of ≤ 15 and > 15 mg/L, comparison of clinical findings, drug use, surgeries and related factors
Index serum CRP level during relapse (mg/L)15> 15P-value
LCRPHCRP
Clinical findings
Mean number of relapses per year (SD)0.25 (0.16)0.36 (0.24)< 0.05
Mean severity of the index relapse according to endoscopic reports, on a 10 points visual analogue scale (SD)3.18 (1.09)4.39 (1.24)< 0.001
Drug use
Number of patients with prednisone use23 (85.2%)62 (92.5%)NS
Mean number of days of prednisone use per year (SD)158 (48)107 (95)< 0.05
Surgeries
Number of patients who underwent ≥ 1 surgeries12 (44.4%)27 (37.3)NS
Total number of surgeries232.0 (0.6)1.7 (0.09)NS
Related factors
Smoking: n2358
smokers8 (34.8%)24 (41.4%)NS
non-smokers11 (47.8%)24 (41.4%)
quitted smokers4 (17.4%)10 (17.2%)
Presence of granulomas: n2251
8 (36.4%)25 (49.0%)NS